Abstract

Psychedelic drugs are potent modulators of conscious states and therefore powerful tools for investigating their neurobiology. N,N, Dimethyltryptamine (DMT) can rapidly induce an extremely immersive state of consciousness characterized by vivid and elaborate visual imagery. Here, we investigated the electrophysiological correlates of the DMT-induced altered state from a pool of participants receiving DMT and (separately) placebo (saline) while instructed to keep their eyes closed. Consistent with our hypotheses, results revealed a spatio-temporal pattern of cortical activation (i.e. travelling waves) similar to that elicited by visual stimulation. Moreover, the typical top-down alpha-band rhythms of closed-eyes rest were significantly decreased, while the bottom-up forward wave was significantly increased. These results support a recent model proposing that psychedelics reduce the 'precision-weighting of priors', thus altering the balance of top-down versus bottom-up information passing. The robust hypothesis-confirming nature of these findings imply the discovery of an important mechanistic principle underpinning psychedelic-induced altered states.

Highlights

  • N,N, Dimethyltryptamine (DMT) is a mixed serotonin receptor agonist that occurs endogenously in several organisms (Christian et al, 1977; Nichols, 2016) including humans (Smythies et al, 1979), albeit in trace concentrations

  • As demonstrated by both theoretical and experimental evidence (Nunez, 2000; Nunez and Srinivasan, 2014; Nunez and Srinivasan, 2009), in most systems, including the human brain, travelling waves occur in groups over some range of spatial wavelengths having multiple spatial and temporal frequencies

  • Such decrease in oscillatory power is matched by a similar decrease induced by visual stimulation. These results demonstrate that, despite participants having their eyes-closed throughout, DMT produces spatio-temporal dynamics similar to those elicited by true visual stimulation

Read more

Summary

Introduction

N,N, Dimethyltryptamine (DMT) is a mixed serotonin receptor agonist that occurs endogenously in several organisms (Christian et al, 1977; Nichols, 2016) including humans (Smythies et al, 1979), albeit in trace concentrations. DMT, which is a classic psychedelic drug, is taken exogenously by humans to alter the quality of their consciousness. DMT is metabolized in the gastrointestinal (GI) system before reaching the brain. Modern scientific research has mostly focused on intravenously injected DMT. Administered in this way, DMT’s subjective effects have a rapid onset, reaching peak intensity after about 2–5 min and subsiding thereafter, with negligible effects felt after about 30 min (Strassman, 2001; Strassman, 1995a; Timmermann et al, 2019)

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call